GSK-3β inhibitor 1 modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3β.
Molecular Weight
222.24
Molecular Formula
C14H10N2O
Targets
GSK-3β: 4.9 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK-3β inhibitor 1 is used to investigate its impact on GSK-3β related pathways in disease models.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
